Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 117 Triple Negative Breast Neoplasms 27 Neoplasm Metastasis 15 Ovarian Neoplasms 5 Brain Neoplasms 4 Neoplasms 3 Inflammatory Breast Neoplasms 3 HER2-negative Breast Cancer 3 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Breast Cancer 2 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neurotoxicity Syndromes 1 Neoplastic Cells, Circulating 1 Neoplasm, Residual 1 Metastatic HER2-positive Breast Cancer 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Melanoma 1 Lung Neoplasms 1 Ketosis 1 Inoperable Locally Advanced HER2-Negative Breast Cancer 1 HR+HER2- Breast Cancer 1 HR Positive HER2 Negative Advanced Breast Cancer 1 HER2-negative Metastatic Breast Cancer 1

Interventions

Paclitaxel 3 Acupuncture Therapy 3 Glutamine 2 Fatty Acids, Omega-3 2 Cryotherapy 2 eribulin 1 Yoga 1 Vitamin D 1 Vitamin B 6 1 Vitamin B 12 1 Thioctic Acid 1 Taxoids 1 Surveys and Questionnaires 1 Sugars 1 Sodium Chloride 1 Silymarin 1 Saline Solution 1 Physical Therapy Modalities 1 Pentoxifylline 1 Omacor 1 Minocycline 1 Methods 1 Metformin 1 Massage 1 Magnetic Resonance Spectroscopy 1 Losartan 1 Lidocaine 1 Hydroxychloroquine 1 Fumigant 93 1 Fish Oils 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peripheral Nervous System Diseases × eribulin × Breast × Clear all

NCT03027245 2022-07-13

IRENE

Eisai Inc.

Breast Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡